Literature DB >> 8882875

Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children.

C C Shoulders1, T T Grantham, J D North, A Gaspardone, F Tomai, A de Fazio, F Versaci, P A Gioffre, N J Cox.   

Abstract

Hypertriglyceridemia is a common metabolic disorder with a major inherited component. In some individuals the condition is suspected to occur as a result of overproduction of apolipoprotein (apo)CIII, a major constituent of triglyceride-rich lipoproteins. Population studies have established an association with the apoCIII gene but the identify of the causal mutation remains unknown. In the present study we have examined a series of six 5' polymorphic nucleotides (G-935 to A, C-641 to A, G-630 to A, deletion of T-625, C-482 to T, and T-455 to C) that lie within the promoter region of the apoCIII gene for evidence of possible involvement in disease susceptibility. The polymorphic nucleotides at positions -455 and -482 reside within a negative insulin-response element. We show, in a community-based sample of 503 school children, that a DNA polymorphism (S2 allele) within the 3'-noncoding region of the apoCIII gene was associated with elevated apoCIII and triglyceride levels, but that the polymorphic nucleotides of the promoter were not. In addition, no obvious effect of any extended apoCIII promoter haplotype on plasma apoCIII or triglyceride levels, over and above that conferred by the presence of the S2 polymorphic nucleotide, was detected. These results demonstrate that none of the 5' apoCIII polymorphisms can account for the association of the apoCIII gene locus with hypertriglyceridemia and, moreover, owing to linkage disequilibrium, raise the possibility that the region conferring susceptibility maps downstream, rather than upstream, of the apoCIII gene promoter sequences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882875     DOI: 10.1007/s004390050259

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  Study of apolipoproteinc3 Sstl polymorphism in healthy volunteers from Northern India.

Authors:  S Chhabra; D P Agarwal; S Vasisht; K Luthra; R Narang; S C Manchanda; L M Srivastava; N Das
Journal:  Indian J Clin Biochem       Date:  2003-07

2.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

Authors:  G M Dallinga-Thie; M van Linde-Sibenius Trip; J I Rotter; R M Cantor; X Bu; A J Lusis; T W de Bruin
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

3.  Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.

Authors:  Sophie Eichenbaum-Voline; Michael Olivier; Emma L Jones; Rossitza P Naoumova; Bethan Jones; Brian Gau; Hetal N Patel; Mary Seed; D John Betteridge; David J Galton; Edward M Rubin; James Scott; Carol C Shoulders; Len A Pennacchio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

4.  Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.

Authors:  S Chhabra; R Narang; R Lakshmy; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

5.  Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians.

Authors:  Christophe Garenc; Samuel Aubert; Jèrôme Laroche; Joël Girouard; Marie-Claude Vohl; Jean Bergeron; François Rousseau; Pierre Julien
Journal:  J Hum Genet       Date:  2004-11-12       Impact factor: 3.172

6.  Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.

Authors:  Andrea S Foulkes; David A Wohl; Ian Frank; Elaine Puleo; Stephanie Restine; Megan L Wolfe; Michael P Dube; Pablo Tebas; Muredach P Reilly
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

7.  Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Authors:  Yongyan Song; Liren Zhu; Mudwari Richa; Ping Li; Yang Yang; Suping Li
Journal:  Lipids Health Dis       Date:  2015-04-18       Impact factor: 3.876

8.  Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians.

Authors:  S Chhabra; R Narang; L R Krishnan; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  BMC Genet       Date:  2002-06-06       Impact factor: 2.797

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.